B. Metzler Seel. Sohn & Co. Ag Repligen Corp Transaction History

B. Metzler Seel. Sohn & Co. Ag

$10 Billion
Q3 2024

A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Repligen Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 7,973 shares of RGEN stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,973

Previous 10,929 27.05%

Holding current value

$1.19 Million

Previous $1.38 Million 13.87%

% of portfolio

0.01%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$119.79 - $167.35 $354,099 - $494,686	-2,956 Reduced 27.05%	7,973 $1.19 Million
Q2 2024 Aug 13, 2024	BUY	$120.0 - $182.95 $7,320 - $11,159	61 Added 0.56%	10,929 $1.38 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $84,877 - $103,584	-497 Reduced 4.37%	10,868 $2 Million
Q4 2023 Feb 13, 2024	BUY	$114.17 - $185.35 $99,784 - $161,995	874 Added 8.33%	11,365 $2.04 Million
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $527,502 - $670,914	-3,801 Reduced 26.6%	10,491 $1.67 Million
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $983,058 - $1.28 Million	7,102 Added 98.78%	14,292 $2.02 Million
Q1 2023 May 10, 2023	BUY	$154.26 - $198.1 $83,146 - $106,775	539 Added 8.1%	7,190 $1.21 Million
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $162,095 - $220,118	998 Added 17.65%	6,651 $1.13 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $22,619 - $36,125	141 Added 2.56%	5,653 $1.06 Million
Q1 2022 May 10, 2022	BUY	$161.19 - $257.96 $888,479 - $1.42 Million	5,512 New	5,512 $1.04 Million

Others Institutions Holding RGEN

# of Institutions

475

Shares Held

54.9M

Call Options Held

314K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.3B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.

Account

B. Metzler Seel. Sohn & Co. Ag Repligen Corp Transaction History